3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
86
Breast Neoplasms
48
Prostatic Neoplasms
43
Squamous Cell Carcinoma of Head and Neck
34
Lung Neoplasms
24
Stomach Neoplasms
18
Neoplasms
18
Head and Neck Neoplasms
17
Neoplasm Metastasis
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
14
Urinary Bladder Neoplasms
13
Carcinoma, Transitional Cell
11
Triple Negative Breast Neoplasms
10
Ovarian Neoplasms
8
Endometrial Neoplasms
8
Carcinoma, Squamous Cell
8
Adenocarcinoma
8
HER2-positive Breast Cancer
7
Non-Muscle Invasive Bladder Neoplasms
6
Melanoma
6
Carcinoma
6
Small Cell Lung Carcinoma
5
Prostatic Neoplasms, Castration-Resistant
5
Nasopharyngeal Carcinoma
5
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Sarcoma
4
Oropharyngeal Neoplasms
4
Fallopian Tube Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Interventions
fludarabine
52
Cyclophosphamide
50
venetoclax
47
Azacitidine
44
fludarabine phosphate
41
Whole-Body Irradiation
33
Specimen Handling
31
Mycophenolic Acid
30
Tacrolimus
28
Melphalan
28
Busulfan
27
Cytarabine
25
Stem Cell Transplantation
23
Decitabine
23
Biopsy
22
Granulocyte Colony-Stimulating Factor
19
Sirolimus
16
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Thiotepa
15
decitabine and cedazuridine drug combination
14
Injections
13
Cyclosporine
13
Methotrexate
9
Mesna
9
Hematopoietic Stem Cell Transplantation
9
ruxolitinib
8
X-Rays
8
Idarubicin
8
Daunorubicin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Docetaxel
×
1 year
×
Clear all
No trials found.